To access the full text documents, please follow this link: http://hdl.handle.net/2445/132979
dc.contributor.author | Soler, Adriana |
---|---|
dc.contributor.author | Figueiredo, Ana M. |
dc.contributor.author | Castel Morales, Pau |
dc.contributor.author | Martín Fernández, Laura |
dc.contributor.author | Monelli, Erika |
dc.contributor.author | Angulo Urarte, Ana |
dc.contributor.author | Milà-Guasch, Maria |
dc.contributor.author | Viñals Canals, Francesc |
dc.contributor.author | Baselga, Jose |
dc.contributor.author | Casanovas i Casanovas, Oriol |
dc.contributor.author | Graupera i Garcia-Milà, Mariona |
dc.date | 2019-05-10T14:42:47Z |
dc.date | 2019-05-10T14:42:47Z |
dc.date | 2016-12-01 |
dc.date | 2019-05-10T14:42:47Z |
dc.identifier.citation | 1078-0432 |
dc.identifier.citation | 662999 |
dc.identifier.uri | http://hdl.handle.net/2445/132979 |
dc.format | 13 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | American Association for Cancer Research |
dc.relation | Versió postprint del document publicat a: https://doi.org/10.1158/1078-0432.CCR-15-3051 |
dc.relation | Clinical Cancer Research, 2016, vol. 22, num. 23, p. 5805-5817 |
dc.relation | https://doi.org/10.1158/1078-0432.CCR-15-3051 |
dc.rights | (c) American Association for Cancer Research, 2016 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.subject | Pàncrees |
dc.subject | Inhibidors de fosfodiesterases |
dc.subject | Farmacologia |
dc.subject | Pancreas |
dc.subject | Phosphodiesterase Inhibitors |
dc.subject | Pharmacology |
dc.title | Therapeutic benefit of selective inhibition of p110α PI3-kinase in pancreatic neuroendocrine tumors |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/acceptedVersion |
dc.description.abstract |